This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mountzouros, K. T.
Right arrow Articles by Howell, A. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mountzouros, K. T.
Right arrow Articles by Howell, A. P.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, August 2000, p. 2878-2884, Vol. 38, No. 8
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Detection of Complement-Mediated Antibody-Dependent Bactericidal Activity in a Fluorescence-Based Serum Bactericidal Assay for Group B Neisseria meningitidis

Kenneth T. Mountzouros* and Alan P. Howell

Wyeth-Lederle Vaccines and Pediatrics, West Henrietta, New York 14586-9728

Received 1 February 2000/Returned for modification 11 March 2000/Accepted 17 May 2000

Serum bactericidal assays (SBAs) for Group B meningococci are considered the methods of choice for the evaluation of functional antimeningococcal antibodies. Many investigators regard SBAs as time- and labor-intensive. Variations in SBA protocols among different laboratories make interpretation of results difficult. Here we describe a fluorescence-based serum bactericidal assay (fSBA) and compare the results obtained with the fSBA to the results obtained with a more conventional SBA. The results generated by both assays were dependent upon the surviving bacteria after incubation, and the assay mixtures contained identical components. Differences between assays lie in how the surviving bacteria are quantified. The fSBA described in the paper uses the fluorescent dye alamarBlue (M. V. Lancaster and R. D. Fields, U.S. patent 5501959, March 1996). The fluorescent signals generated in the fSBA correlate to the oxidative respiration of surviving bacteria. Viable bacteria were detected between 6 and 8 h directly from reaction mixtures in 96-well plates by the fSBA, whereas colonies isolated on semisolid media could be counted after 24 h of incubation. The bactericidal titers generated by both assays were nearly identical. The fSBA described here can be used as an assay for the screening of large quantities of individual sera as complement sources or as a method for the detection of functional antibodies directed against group B Neisseria meningitidis in both human and mouse antisera.

* Corresponding author. Mailing address: Wyeth-Lederle Vaccines, 211 Bailey Rd., West Henrietta, NY 14586-9728. Phone: (716) 273-7606. Fax: (716) 273-7515. E-mail: mountzk{at}war.wyeth.com.

Journal of Clinical Microbiology, August 2000, p. 2878-2884, Vol. 38, No. 8
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Zhu, D., Zhang, Y., Barniak, V., Bernfield, L., Howell, A., Zlotnick, G. (2005). Evaluation of Recombinant Lipidated P2086 Protein as a Vaccine Candidate for Group B Neisseria meningitidis in a Murine Nasal Challenge Model. Infect. Immun. 73: 6838-6845 [Abstract] [Full Text]  
  • Bieging, K. T., Rajam, G., Holder, P., Udoff, R., Carlone, G. M., Romero-Steiner, S. (2005). Fluorescent Multivalent Opsonophagocytic Assay for Measurement of Functional Antibodies to Streptococcus pneumoniae. CVI 12: 1238-1242 [Abstract] [Full Text]  
  • Fletcher, L. D., Bernfield, L., Barniak, V., Farley, J. E., Howell, A., Knauf, M., Ooi, P., Smith, R. P., Weise, P., Wetherell, M., Xie, X., Zagursky, R., Zhang, Y., Zlotnick, G. W. (2004). Vaccine Potential of the Neisseria meningitidis 2086 Lipoprotein. Infect. Immun. 72: 2088-2100 [Abstract] [Full Text]  
  • Romero-Steiner, S., Spear, W., Brown, N., Holder, P., Hennessy, T., Gomez de Leon, P., Carlone, G. M. (2004). Measurement of Serum Bactericidal Activity Specific for Haemophilus influenzae Type b by Using a Chromogenic and Fluorescent Metabolic Indicator. CVI 11: 89-93 [Abstract] [Full Text]  
  • Mountzouros, K. T., Belanger, K. A., Howell, A. P., Bixler, G. S. Jr., Madore, D. V. (2002). A Glycoconjugate Vaccine for Neisseria meningitidis Induces Antibodies in Human Infants That Afford Protection against Meningococcal Bacteremia in a Neonate Rat Challenge Model. Infect. Immun. 70: 6576-6582 [Abstract] [Full Text]  
  • Martinez, J., Pilishvili, T., Barnard, S., Caba, J., Spear, W., Romero-Steiner, S., Carlone, G. M. (2002). Opsonophagocytosis of Fluorescent Polystyrene Beads Coupled to Neisseria meningitidis Serogroup A, C, Y, or W135 Polysaccharide Correlates with Serum Bactericidal Activity. CVI 9: 485-488 [Abstract] [Full Text]  
  • Rodriguez, T., Lastre, M., Cedre, B., Campo, J. d., Bracho, G., Zayas, C., Taboada, C., Diaz, M., Sierra, G., Perez, O. (2002). Standardization of Neisseria meningitidis Serogroup B Colorimetric Serum Bactericida Assay. CVI 9: 109-114 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»